JOSEPH PAULSON: Open Payments
NPI 1477582252 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 36 payments from 15 companies in 2025. Trend: 2023 $842 · 2024 $768 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $159 |
| PFIZER INC. | 6 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Astellas Pharma US Inc | 3 | $71 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
Products named: Ozempic, PREVNAR 20, Veozah, Wegovy, ELIQUIS, FARXIGA, GEMTESA, BREZTRI.
Industry payments across GA — which companies pay providers there.
